Background Helicobacter pylori is one of the most prevalent global pathogens and can lead
to gastrointestinal disease including peptic ulcers, gastric marginal zone lymphoma and …

Helicobacter pylori (H. pylori) is an extremely common, yet underappreciated, pathogen that
is able to alter host physiology and subvert the host immune response, allowing it to persist …

Helicobacter pylori (H. pylori) is a common gastrointestinal bacterial strain closely
associated with the incidence of chronic gastritis, peptic ulcers, gastric mucosa-associated …

Helicobacter pylori (H. pylori) infection is highly associated with the occurrence of
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …

Fluoroquinolones are one of the most promising and vigorously pursued areas of
contemporary antiinfective chemotherapy depicting broad spectrum and potent activity. They …

Increasing rates of Helicobacter pylori resistance are associated with multiple clinical
challenges. Bacterial factors linked to H. pylori resistance are mutations, efflux pumps, and …

Helicobacter pylori is a major human pathogen. Diagnosis of H. pylori infection and
determination of its antibiotic susceptibility still mainly rely on culture and phenotypic drug …

Eradication therapy for Helicobacter pylori is recommended in a number of clinical
conditions. In this article, we discuss the epidemiology and cellular mechanisms that result …

Helicobacter pylori, a human pathogen with a high global prevalence, is the causative
pathogen for multiple gastrointestinal diseases, especially chronic gastritis, peptic ulcers …

Helicobacter pylori (H. pylori) antibiotic resistance is the main factor affecting the efficacy of
the current eradicating therapies. The aim of this editorial is to report on the recent …